Clinical Trial Update: Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating HG146 in participants with Adenoid Cystic Carcinoma and related head and neck cancers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma
• Head and Neck Cancer

Drugs mentioned

• HG146

Snippet

Sponsor: HitGen Inc. | Conditions: Adenoid Cystic Carcinoma, Head and Neck Cancer | Phase 2 | Status: RECRUITING